Vimarsana
Biggest News Aggregation in the World

Page 10 - Recursion Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recursion Pharmaceuticals Today - Breaking & Trending Today

It's not just chips. Nvidia is betting on other tech that could be impacted by AI. - Vimarsana News

It's not just chips. Nvidia is betting on other tech that could be impacted by AI.

Nvidia's chips primed the company to leverage the latest artificial-intelligence boom.But the GPU-maker is targeting other areas where AI could apply.The California

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling - Vimarsana News

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]

Source: wkrb13.com
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 6.1% on Insider Selling - Vimarsana News

Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 6.1% on Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday following insider selling activity. The stock traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares changed hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. The stock had previously […]

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling - Vimarsana News

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates - Vimarsana News

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

There's been a notable change in appetite for Recursion Pharmaceuticals, Inc. ( NASDAQ:RXRX ) shares in the week since...

Source: yahoo.com